Literature DB >> 34126339

Anti-asthmatic effects of tannic acid from Chinese natural gall nuts in a mouse model of allergic asthma.

Nandhine Rajasekar1, Ayyanar Sivanantham1, Amrita Kar2, Sramana Mukhopadhyay3, Santanu Kar Mahapatra2, Sudhakar Gandhi Paramasivam4, Subbiah Rajasekaran5.   

Abstract

Asthma is a chronic inflammatory disease of the airways, which is characterized by infiltration of inflammatory cells, airway hyperresponsiveness (AHR), and airway remodeling. This study aimed to explore the role and mechanism of tannic acid (TA), a naturally occurring plant-derived polyphenol, in murine asthma model. BALB/c mice were given ovalbumin (OVA) to establish an allergic asthma model. The results revealed that TA treatment significantly decreased OVA-induced AHR, inflammatory cells infiltration, and the expression of various inflammatory mediators (Th2 and Th1 cytokines, eotaxin, and total IgE). Additionally, TA treatment also attenuated increases in mucins (Muc5ac and Muc5b) expression, mucus production in airway goblet cells, mast cells infiltration, and airway remodeling induced by OVA exposure. Furthermore, OVA-induced NF-κB (nuclear factor- kappa B) activation and cell adhesion molecules expression in the lungs was suppressed by TA treatment. In conclusion, TA effectively attenuated AHR, inflammatory response, and airway remodeling in OVA-challenged asthmatic mice. Therefore, TA may be a potential therapeutic option against allergic asthma in clinical settings.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Airway inflammation; Airway remodeling; Asthma; NF-κB; Natural compound; Tannic acid

Mesh:

Substances:

Year:  2021        PMID: 34126339     DOI: 10.1016/j.intimp.2021.107847

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  1 in total

1.  Co-Application with Tannic Acid Prevents Transdermal Sensitization to Ovalbumin in Mice.

Authors:  Eri Izumi; Nana Tanahashi; Serina Kinugasa; Shota Hidaka; Nobuhiro Zaima; Tatsuya Moriyama
Journal:  Int J Mol Sci       Date:  2022-04-01       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.